Literature DB >> 3553946

Enzyme-substitution therapy with the yeast Saccharomyces cerevisiae in congenital sucrase-isomaltase deficiency.

H K Harms, R M Bertele-Harms, D Bruer-Kleis.   

Abstract

Sucrase-isomaltase deficiency is an inherited disaccharidase deficiency that leads to malabsorption of sucrose, with resulting diarrhea and abdominal distention and cramps. We investigated the sucrose-splitting effect of viable yeast cells in eight children with congenital sucrase-isomaltase deficiency, by means of the sucrose hydrogen breath test. This test is based on the fact that hydrogen is released from the malabsorbed sucrose by the colonic microflora. We found that 0.3 g of lyophilized Saccharomyces cerevisiae, given after loading with 2 g of sucrose per kilogram of body weight, reduced hydrogen excretion in all patients, on average by 70 percent, in parallel with a complete loss or evident reduction of clinical symptoms. In vitro, lyophilized and fresh S. cerevisiae (fresh baker's yeast) had appreciable sucrase activity, a low isomaltase and maltase activity, and virtually no lactase activity. The sucrase activity was more inhibited by undiluted than by diluted gastric juice. We conclude that patients with congenital sucrase-isomaltase deficiency who intentionally or unintentionally consume sucrose can ameliorate the malabsorption by subsequently ingesting a small amount of viable yeast cells, preferably on a full stomach.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553946     DOI: 10.1056/NEJM198705213162104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

Review 1.  Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.

Authors:  Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2013-11-02       Impact factor: 4.200

2.  From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health.

Authors:  William D Fiers; Irina Leonardi; Iliyan D Iliev
Journal:  Annu Rev Nutr       Date:  2020-07-17       Impact factor: 11.848

Review 3.  Effects of Saccharomyces boulardii on intestinal mucosa.

Authors:  Jean-Paul Buts; Nadine De Keyser
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

Review 4.  Probiotics in clinical conditions.

Authors:  Philippe R Marteau
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

5.  Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers.

Authors:  S M Klein; G W Elmer; L V McFarland; C M Surawicz; R H Levy
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

6.  Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment.

Authors:  S Blanquet; J P Meunier; M Minekus; S Marol-Bonnin; M Alric
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

7.  Influence of orocaecal transit time on hydrogen excretion after carbohydrate malabsorption.

Authors:  J J Rumessen; O Hamberg; E Gudmand-Høyer
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

8.  The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.

Authors:  Atakan Sezer; Ufuk Usta; Irfan Cicin
Journal:  Med Oncol       Date:  2008-12-09       Impact factor: 3.064

9.  13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients.

Authors:  Claudia C Robayo-Torres; Antone R Opekun; Roberto Quezada-Calvillo; Xavier Villa; E O Smith; Marilyn Navarrete; Susan S Baker; Buford L Nichols
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-04       Impact factor: 2.839

10.  Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice.

Authors:  S Pecquet; D Guillaumin; C Tancrede; A Andremont
Journal:  Appl Environ Microbiol       Date:  1991-10       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.